CSL - Pre Tax Profit

Stock Price
141.48
Daily Change
-0.70 -0.49%
Monthly
-2.13%
Yearly
-41.48%
Q2 Forecast
135.92

CSL reported $2.61B in Pre-Tax Profit for its fiscal semester ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Immunic USD -21.38M 8.2M Jun/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024